Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Meloxicam launched in Great Britain

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

U.S. patent covers hemopoietic regulator with potential in rheumatoid arthritis

Sep. 27, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.